Portfolio Adjustment: Institutional Heavyweight Exits Biotech Stock
On November 14, 2025, Bain Capital Life Sciences Investors, LLC, disclosed a full exit from Disc Medicine (NASDAQ:IRON), reducing its position by approximately $30.90 million.
Bain Capital Life Sciences Investors, LLC, sold its entire stake in Disc Medicine during the third quarter of 2025, according to a filing with the Securities and Exchange Commission dated November 14, 2025. The fund’s holding decreased by 583,500 shares, eliminating the position and resulting in a $30,902,160 net reduction.
This was a complete sale, bringing the stake to 0% of the fund’s 13F assets under management.
Source Fool.com